863
www.neurologiepropraxi.cz34080430107651332012142633073553814284484965465656086586857327828098518919109269661005
/33848043010732
Neurol.3461804301075593139165209227243
praxi.3720804301074672114152170186
2023;24(4):264-2673922804301074487128172186230270295336357372416459505534573615656
/46238043010732
NEUROLOGIE47018043010757101158205267310369428449493
PRO5216804301074591153
PRAXI5391804301074591147200221
26756558026012657114170
PŘEHLEDOVÉ4549207012660124182256312369444520587645
ČLÁNKY5216207012660115187259327395
Zlepšení17363650106316294129163194235253
kognitivních200536501063372112153170202220258300317351393
funkcí241336501062970111147180197
a2626365010638
zaměstnanosti268036501063072126158192225266306347388421453471
u3167365010639
pacientů322136501063370103121152194226267
s3504365010631
relabující35513650106336596138174215238256290308
formou387436501062970106161201242
roztroušené413236501063374105139175216257289321362394
sklerózy45423650106306597129165206237276
léčených48343650106296196128169206239280
okrelizumabem513036501063874110142174191224265319359395427482
3.3405530853550
Benedict4025540833569106140179193224248
RHB,6625540833579114126
Comi8005540833975132147
G,9595540834356
Oreja‑Guevara10275540834667100115146168213250284316348368400
C,14405540833951
et15035540833455
al.1570554083324659
Cognitive16415540833975114151165187202233267
Improvements19205540831471340654083386096128162219254291313340
in6936540831452
Ocrelizumab‑Treated7576540834779100134149164192230287319358381411428462493514548587
Patients1356654083356788103138175196224
withRelapsing­1592654083516688126161196211243282308323360399420
‑Remitting340754083215892150165187211226264303
Multiple6557540835592107129145183199234
Sclerosis:901754083336580114136173199214240252
96-Week1166754083346992149182217247
CASTING14267540834082116150166211255
Study1694754083325391130161
Data.1868754083457799131145
Available3408540834275109126142177218235272
from:640854083194282143156
https://medically.roche.com/global/en/8248540833862881291581712002222813183593764104444614785115235465856206606977107447838448729109269661008104310601087112111611188
medical‑material.c5dd6233-0990-4770-9208-35fcfea91235.340954083589313314818021322925131034336539942043646848349652956460364267871274778080283987591094697010071039107411071131116612001234127012931325135813761408142914641496153015621592162716601672
qr.html?cid=slprxx2210nexxectrims2022.3401054083385970108130188203230259274313356383398437458491524560595627658697732764797831863888909925982100910431077111011451157
4.34011530853754
Brownlee43011540833660100154195213250288
WJ,7541154083598296
Hardy88611540834580104144179
TA,11001154083347490
Fazekas12251154083346698134167203232
F,149311540833340
et156911540833560
al.16641154083335065
Diagnosis176511540834664981401812223401254083274269
of43112540833858
multiple51012540835998114137153193210246
sclerosis:7771254083276076112134173200216243256
progress105412540834062101142164199227254
and132912540833372112
challenges.146312540833271104120136172211252288316330
Lancet.1814125408330661041341641862000125408312
2017;389(10076):1336-46.34013540833468100129139174209243262294325361394426444456486516549583606643679692
5.34014530853650
Campbell41114540834073131170209245260276
J,70714540832436
Rashid7631454083356894132147186
W,96914540835867
Cercignani10561454083407495126141180218251289304
M,138014540835468
et146814540833456
al.15441454083324760
Cognitive162414540834077116154169192207240274
impairment1918145408315723401554083397288109168203242263
among62415540833290129168207
patients8521554083397294109144183205233
with11051554083516790128
multiple125415540835895111134149189205240
sclerosis:15141554083275975110131169196211237250
associations178515540833258851241571722043401654083223775114141
with5011654083516789128
employment64916540833493132148187218277312351372
and104216540833270109
quality117216540833876108124139162196
of138816540833857
life.146616540831530498496
Postgrad15831654083336892113148169203239
Med183916540835383120
J.197616540832437
2017;93(1097):143-147.34017540833468100129139175207226257289324357376388418449482503534565597604
6.34018530853753
Castelo‑Branco41418540834174102125160176215239277299333372405443
A,87818540834156
Landfeldt95518540833267105145165201217257280
E,125618540833347
Svedbom132418540833365100140180220280
A,162518540834256
et170218540833558
al.17811854083324862
Clinical186418540834056721101263401954083326783
course44619540833270110132161198
of66619540833959
multiple74819540835998115138154195212249
sclerosis10191954083276177114136175203219246
and128819540833372113
labour‑force14241954083154990130170192213234273296329364
absenteeism:1811195408332731011381783402054083225693108135194206
a567205408332
longitudinal6202054083155494133149172211251266305338354
population‑based99520540833979119158174207229245283323346387420447483524
study.15402054083265089128161171
Eur17332054083316788
J1838205408325
Neu‑188020540834374111133
rol.3402154083205570409215408312
2019;26(4):603–9.43721540833468100130143178211230263280292328363396433467478
7.34022530853544
Chen39622540833977111148
J,55622540832436
Taylor6042254083326090105143164
B,78022540833547
Palmer8402254083346680137171192
AJ,10442254083416779
et113522540833456
al.12032254083314659
Estimating1274225408332598297153185206221258296
MSrelated158322540835386106139155186207240279
work187422540835087108138
productivity3402354083386097136174206229245277293315348
loss7012354083155379106
and82023540833169108
factors9412354083185183107144165192
associated11462354083325884122155170202223257296
with14552354083506688126
work159423540835088109139
productivity174623540833960971361742062302453402454083314769102
loss4552454083155279105
in57324540831452
a637245408332
representative6812454083215493115148175209247268301322337369403
Australian109724540834077103126147179194209241278
sample138824540832659116155170205
of160524540833756
people167424540833873112151166201
with18872454083516688126
multiple34025540835795110133148187203238
sclerosis.5932554083265874109130167194209235248
Mult85725540835389104124
Scler.99425540833160751051261116255408312
2019;25(7):994-1004.114425540833468100130143178212230265284296331367402425456488524560573
8.34026530853651
Dorstyn40426540834583104131154187225
DS,6422654083447789
Roberts74426540833572111146167191219
RM,97526540833590103
Murphy109026540835492112151189220
G,132226540834356
et139126540833455
al.14592654083314659
Employment153026540833390128144181212270304342363
and190626540833168107
multiple34027540835795110133148187203238
sclerosis:5982754083275974109130168194209235248
a866275408332
meta‑analytic91827540835893115148171203241273289320345361393
review13312754083215587103138189
of154027540833757
psychological16172754083396698130168206222260300315347380395
correlates.3402854083316890111146161193215249276289
J645285408324
Health68228540834272108123144180
Psychol.8742854083345887117153189204217
2019;24(1):38-51.110628540833468100130143178210229261275287323357380414445454
9.34029530853649
García‑Domínguez4012954083437596126141172194241279336351388426463498527
JM,9402954083247891
Maurino104329540835486123143159196233
J,128929540832435
Martínez‑Ginés133729540835485106130145182217246267313328365399426
ML,17752954083548599
et188629540833355
al.19542954083314658
Economic34030540833364101139178236251283
burden6383054083397798137171210
of86330540833757
multiple93530540835795110133148187203238
sclerosis11883054083275974109130167194209235
in143930540831452
a1507305408331
population155430540833977117155170203224240278316
with18863054083506688126
low34031540831553104
physical45931540833978108135150182215230
disability.7053154083385379112151167182197219253263
BMC98431540833487125
Public112231540833368104119134163
Health.129831540834273108123144180194
2019;19(1):609.150431540833468100130143173203222254269280316351387398
10.3403253085367085
Glanz4393254083446092130159
BI,6123254083355164
Dégano68932540834681121153191229
IR,9323254083155165
Rintell10103254083365189111144160175
DJ,11993254083456880
et129232540833457
al.13623254083324861
Work143632540835894116146
productivity15963254083396098137175207231246279295317351
in196132540831452
relapsing3403354083215570103142168183221260
multiple61733540835794110132147187202237
sclerosis:8713354083265873108129167193208234247
associations11343354083325885123156171203225240278317343
with14933354083516689127
disability,16363354083395480113152168183198220254264
depression,1916335408338733403454083396094121148163201239252
fatigue,606345408318527489128165200212
anxiety,83334540833169101116151173207217
cognition,106434540833168108146161183199237275288
and136634540833270109
healthrelated148934540833873105120142181202236251284305339379
quality188234540833876108340355408315305286
of44135540833857
life.51335540831530498496
Value6243554083356883119149
Health.78635540834272108123144180193
2012;15(8):99535540833468100130142172202220254272284
1029-35.12943554083346699133156189222234
11.3403653085366678
Hauser43236540834476114140175197
SL,6423654083326377
Bar‑Or7323654083366990109159181
A,92636540834155
Comi99536540834077135150
G,115836540834457
et122936540833456
al.12983654083324760
Ocrelizumab137136540834780101135151166195233291323363
versus17473654083316687114151178
interferon193836540831552340375408322557798133154191229
beta-1a5833754083397497129152183211
in80837540831552
relapsing8743754083215571103142169183221260
multiple114837540835895110133148187203238
sclerosis.14003754083265873108130167193208234248
N1662375408343
Engl171637540833167102117
J1845375408324
Med.188037540835383119133
2017;376(3):221-34.34038540833468100129139174206238257291308320355390421440472508520
12.3403953085366884
Johnson44039540832462101139165204242
KL,6983954083356881
Yorkston7953954083367091122151174211249
KM,106039540833592105
Klasner11813954083355184110148183204
ER,14013954083336882
et149939540833456
al.15713954083324760
The164739540833372107
cost17703954083316895118
and190439540833270109
benefits21405540833976115151169186209237
of23995540833857
employment:24785540833493133150189221281317356378392
a289155408333
qualitative29455540833877110126141165198221236270305
study3271554083275089129162
of34545540833858
experiences353355408335671081441661822182572140654083316592
of22516540833757
persons2327654083397495123161199226
with2572654083516689127
multiple27186540835795110133148187203238
sclerosis.2975654083265974109130167194209235248
Arch3243654083385887123
Phys3382654083336997122
Med35206540835283119
Reha‑36556540833464101136158
bil.214075408335506578
2004;85(2):201-9.22347540833468104141152188222239273291303338372404423458469
13.2140853085366883
Julian223985408324627792124162
LJ,2417854083325971
Vella250485408335688499131
L,26518540833145
Vollmer2712854083357187102160195216
T,29448540833342
et30028540833456
al.3074854083314760
Employment31508540833290129145183214273308346368
in35348540831452
multiple3602854083579511013314818721409540831550
sclerosis.2206954083265874108130167194208234248
Exiting2470954083336581103119157196
and26829540833170109
re‑entering2807954083205478114152174207229244282321
the3144954083226095
work32559540835189110141
force.3412954083185677109142154
J358395408324
Neurol.36209540834373110130165180193
2008;255(9):1354-60.214010540833468104140152187222254272305322334364394427462485522558571
14.21401153085366984
Kappos224011540833568108147186213
L,246811540833245
Wolinsky252911540835794110125162189219253
JS,27971154083245669
Giovannoni28821154083435997129162200238276314329
G,322711540834457
et330011540833456
al.33711154083324861
Contribution344711540834077115137158174213251274289327366
of214012540833757
Relapse‑Independent22111254083357086118157184219242258296336370410445483522557595617
Progression28421254083355693133154188215241256294332
vs318912540833158
Relapse‑Associated32611254083367186119158184219243284312338377409424456478512551
Worsening214013540835794115143178216231269308
to246313540832259
Overall253713540834780115136169184199
Confirmed275213540833976115132149170229264303
Disability30711354083456087120159174190205227261
Accumulation334713540834172103141199237252284306321359398
in376013540831452
Typical214014540833360100116148181196
Relapsing23501454083357085118157184198236275
Multiple263914540835492108130145184200235
Sclerosis28881454083326480115136173200215241
in314214540831553
a3208145408332
Pooled325414540833572110126161201
Analysis346814540834179112127159186201227
of370814540833757
23778145408335
Randomized214015540833568105144182239254283317356
Clinical25091554083395469107121153186201
Trials.2722155408333506597112138151
JAMA288315540832460113151
Neurol.304415540834373109129164178191
2020;77(9):1132-1140.324615540833468100134147179213229262279291321348378410430460488518554566
15.21401653085366883
Landfeldt223616540833165103142161195211250272
E,252116540833346
Castelo‑Branco25801654083407299122156171209232270291324362394431
A,302416540834055
Svedbom30921654083326397136175214272
A,337716540834155
et344516540833456
al.35141654083324760
Sick35871654083334779109
leave37091654083155082214017540833266
and222017540833270109
disability23441754083385379112152167182197220253
pension261217540833974112139153191230
before28561754083397594131153187
and305817540833169108
after31811754083325176109131
diagnosis33261754083385385124163201227242268
of360917540833757
multiple3680175408357951102140185408322377692127
sclerosis.22821854083265874109130167194209235248
Mult254618540835389104124
Scler.26831854083316075105126136
2016;22(14):1859-66.283518540833468100131143178213231262293311323352383417450473511546559
16.21401953085366985
Lehmann224119540833165104161194232270
AI,25271954083415669
Rodgers261119540833674114153188209236
S,286319540833245
Kamm292419540833568126184
CP,31241954083407580
et321919540833457
al.32911954083324861
Factors33671954083336294118155177204
associated3587195408332588512315617120321402054083225595
with22482054083516689127
employment238820540833492131147185217275310349370
and277120540833270109
expected289420540833465105140173197231270
work317820540835088110140
retention33322054083205477110148170185223262
among360720540833290128166205
persons21402154083397495123161199226
with23792154083516689127
multiple252021540835795110132148187203238
sclerosis:27712154083265974109130167194209235247
findings30322154083173472111126164203229
of327521540833756
a3345215408332
cross‑sectional33902154083315390117143164191226259283298336375407422
citizen2140225408331466984113147185
science23412254083265873108146178212
study.25682254083264987126158168
J2749225408324
Neurol.278622540834273109129164179192
2020;267:3069-3082.299422540833468101135148183217250260295329365399423455489525558571
17.21402353085377080
Marck224223540835690112145176
CH,244123540834187101
Aitken25642354083425882114149189
Z,277523540833953
Simpson285023540833450109150178218258
S3131235408333
Jr,31862354083254858
et326623540833559
al.33472354083334963
Predictors34322354083365894135151185210248271300
of375423540833859
change214024540833169102140179213
in236724540831553
employment243324540833492131147185217275310348370
status28172454083264982103141168
and299824540833270109
associations31212454083325885123156171203225240278316343
with34782454083506688126
quality361824540833876108123138161194
of214025540833756
life:220925540831530498496
a2318255408332
prospective23632554083386097124162198230254270302336
international27122554083155374108129168200221237274313345360
study30852554083264987126158
of325625540833756
people332525540833974113153168203
with35412554083506688126
multiple3680255408358951102140265408322377692127
sclerosis.22822654083265874109130167194209235248
J2546265408324
Occup258326540834575104139175
Rehabil.277126540833464101136172187202215
2020;30(1):105-14.300126540833468101135148183218237269283295325356391413443474487
18.21402753085366984
Montalban223727540835492130151184199237270307
X,255727540833851
Hauser262127540834375112138173194
SL,28282754083326276
Kappos291627540833568107146184211
L,313927540833245
et319627540833456
al.32652754083314659
Ocrelizumab33372754083467999133148163192230287319358
versus3707275408332658621402854083266390
placebo22432854083395587119153192231
in248728540831553
primary25532854083396076134166187221
progressive27882854083386097137158192219245260293327
multiple312828540835895111133148187203238
sclerosis.33802854083265873108129167193208234248
N3641285408343
Engl369528540833167102117
J2140295408324
Med.217729540835283119132
2017;376(3):209-20.232229540833468100129139174206238257291308320355389424448479513525
19.21403053085377186
Nicholas22513054083466296136176193227255
JA,25313054083256782
Electricwala26393054083334986120146169186219274309326359
B,302430540833650
Lee309930540833268106
LK,32303054083326985
et334030540833559
al.34243054083335064
Burden35133054083367699139175215
of375330540833959
relapsing‑remitting21403154083215774107148176192232272296319355415431454480496536577
multiple273931540835999115139155196213249
sclerosis30113154083276077113135174202218246
on327931540833979
workers338131540835291114146182204233
in363631540831555
the37143154083226298
US:21403254083457890
a2252325408332
cross‑sectional23063254083325492120148170198234268293309348388421437
analysis276532540833372105121154182198225
of301232540833858
survey30913254083276688124159192
data.33043254083397395129143
BMC346932540833489129
Neurol.3615325408344761131341701863800325408312
2019;19(1):258.214033540833468100130143173203222254269280316351385398
20.21403453085367287
Povolo224234540833572104141157195
CA,24533454083408296
Blair2565345408335518398119
M,269934540835568
Mehta278234540835590128150182
S,298034540833245
Rosehart304034540833574100135174206227252
H,330734540834457
et337934540833456
al.34503454083324861
Predictors35263454083355590129144176200237259286
of214035540833757
vocational221235540833269102135156172210248280296
status25233554083265082104142168
among270735540833189128166205
persons29283554083387495122160199225
with31693554083506688126
multiple331135540835795110132148187203238
sclerosis.35643554083265874109130167194209235248
Mult214036540835389104124
Scler22773654083316075105126
Relat24153654083346579115136
Disord.256336540834460831181391732736365408312
2019;276436540833468100130143
36:101411.29223654083346881111142174205235263272
21.21403753085367082
Reich22373754083357085117155
DS,24073754083467891
Lucchinetti251337540833168101131169184222257280304319
CF,28473754083407379
Calabresi29403754083407389121160182216242257
PA.32123754083357387
Multiple331437540835593108130146185201235
sclerosis.35643754083265974109130167194209235249
N2140385408343
Engl219538540833167103118
J2325385408324
Med.236238540835283119132
2018;378(2):169-80.251038540833468100131143178210244263297315327356387421445481516529
22.21403953085367288
Reilly22443954083357085101116148
Associates.24073954083416995134166181213235269296309
WPAI:273239540835793131146159
SHP290639540833276112
V2.30333954083367184
0.313239540833547
Available319539540834171104119134167206222257
from:34673954083184078136148
http://36313954083375983122135162182
www.reillyassociates.net/wpai_shp.html.3940554083511041571681902242392542693013343613874264584735055275615886016406756977257768168498649019299671006101810571079113711521165
23.3940653085367287
Rumrill40456540833573131152168183198
P,42606540833540
Li43176540833146
J,43806540832436
Strauser4433654083335475108146172207229
D,46786540834657
et47526540833456
al.4825654083324760
Personal,4902654083356890117155194226241254
health51736540833772104119142180
and53706540833270109
function,54966540831857953940754083325672110149162
and41237540833270110
career4254754083316586121157178
maintenance44537540835891106144166200239272310343377
factors4851754083185285109147169196
as50687540833259
determinants5148754083387497131152211227265298336358386
of55557540833857
quality39408540833876108123138161194
of41528540833757
life422785408314294983
among43288540833290128166205
employed45518540833492131147185216251290
people48598540833974113153169203
with5080854083516689127
multiple52258540835795110133148187203238
sclerosis.5481854083265873108394095408321588599126139
Work.40959540835690111140423695408312
2020;67(1):81-94.42649540833468101135148183216233264279291325357376411447459
24.39401053085367186
Simmons404710540833347105163202240267
RD,43341054083368293
Tribe44481054083324965104140
KL,46091054083356881
McDonald471110540835487133171210242258297
EA.50281054083337691
Living5139105408332478096134173
with53321054083516789127
multiple5480105408357951113940115408322387894129
sclerosis:40901154083276076111133171198213240253
longitudinal43641154083155494134151174214254270310343360
changes474611540833271105145185221249
in501811540831554
employment509411540833595135152192224285321361384
and550011540833272112
the394012540832264102
importance407412540831677119161185213248289324361
of446812540833860
symptom456112540832762125167192232294
management.488812540835994135170212250312350391415431
J5352125408325
Neurol.540412540834477116139176194209
2010;257(6):926-36.394013540833469101134147183218252270303322335371405439463496531545
25.39401453085367489
Strober40521454083335577116157193215
L,429014540833146
DeLuca435814540834682116154187221
J,460114540832538
Benedict466114540833672111147188204237262
RH,49461454083358295
et506414540833457
al.51431454083334963
Symbol522814540833364124164204221
Digit547114540834662102118142
Modalities394015540835595136169186202225242278306
Test:42681554083336593118132
a4422155408333
valid4477155408332668399139
clinical46381554083324864103120153187203
trial4864155408322446194111
endpoint499715540833474114155195211251273
for52931554083185780
measuring53951554083589512815619439401654083213776115
cognition407416540833269110148164187203242281
in437416540831553
multiple444716540835795111134150190207242
sclerosis.47081654083276076111133171198214241255
Mult498216540835390105127
Scler.51251654083306076107128139
2019;25(13):528416540833469101132146182217235268298316329
1781-1790.39401754083346498131150182212246282296
26.39401853085367289
Strober40471854083325476114155191213
LB,42791854083316881
Bruce43791854083355796129163
JM,45611854083248094
Arnett467418540834163102138161186
PA,48791854083357388
et498518540833457
al.50611854083324862
A5141185408341
much520118540835796128167
needed538718540833773109149185225
metric:394019540835691113134150182195
Defining41481954083458097114151166204242
reliable4404195408320546984116154170205
and462219540833169107
statistically47431954083254881102118144167182214246261276308
meaningful506419540835691123160175213251271309324
change540219540833068100137176210
of394020540833756
the40092054083215994
oral41162054083375891107
version42362054083316586113128166204
Symbol445320540833261119158197213
Digit46792054083446098114136
Modalities482820540835492131163178193216231266292
Test51342054083326289112
(SDMT).52592054083185094149182204215
Mult548720540835455422054083355070
Scler39402154083316176107128
Relat40822154083346581117139
Disord.42352154083446084120141176190
2022;57:103405.444221540833469103138151187221232262294328364401436448
27.39402253085357079
van403322540833164102
Gorp414922540834381103142
DAM,430522540834584139153
van447222540833164102
der45872254083387394
Hiele46942254083445994110144
K,485222540833449
Heerings491522540834378113135151188227253
MAP,518222540835495131136
et533122540833456
al.54012254083314760
Cognitive5474225408340771163940235408338537692126161
functioning41202354083185796129154170208248263302342
as448123540833159
a4559235408331
predictor46092354083396196136152185210247270
of489823540833757
employment497423540833492132149188220279315353376
status53692354083265083106144171
in555923540831553
relapsing‑remitting39402454083215572104144171187225265288311345404419443467483522561
multiple451624540835795111134150190206242
sclerosis:47722454083265975110132170197213240252
a5037245408332
2-year50822454083345486120152173
longitudinal52682454083155391130145167205244259297329344
study.39402554083264987126158168
Neurol412425540834373109130165180
Sci.4316255408331607588
2019;40(12):2555-2564.441925540833468100130143178214233265295313325360395427460482513548582618631
28.39402653085367288
Walton404526540835789104126163202
C,426426540834053
King43332654083355290129
R,447926540833549
Rechtman454526540833571106145168227261301
L,486526540833247
et493126540833458
al.50092654083314862
Rising5091265408335528096135176
prevalence52862654083396298131166182219258292327
of394027540833758
multiple401427540835796113136153193211247
sclerosis42772754083265976112135173201218245
worldwide:453827540835089112130170222239279316330
insights4883275408315548298138178200229
from51282754083194281140
the52842754083226198
Atlas53972754083416481114142
of555527540833758
MS,394028540835489103
third40612854083226178100140
edition.42192854083347591115132171211226
Mult446328540835390107129
Scler46072854083316278109131
J.475428540832438
2020;16(14):1816-21.481028540833470104139154185218238271304322336367399433465490522555566
29.39402953085367388
Weindel404829540835792109148188225242
H,430929540834458
Benedict438629540833672112148189206239264
RHB,467029540833582119133
Comi482229540834078138155
G,499629540834358
et507429540833357
al.51502954083324963
Employment523229540833392133150189222282319358381
and394030540833271112
Cognitive406730540834079120159175199216250285
Improvements436830540831574115138176210245304341380403432
in481630540831554
Ocrelizumab‑Treated488630540834781103139156172203242301335376400432451486519542578618
Patients55203054083356939403154083223976117141170
with41353154083516993134
Relapsing‑Remitting42933154083367391125167196213253295319358396457474498525542582624
Multiple494131540835596113137155196214251
Sclerosis:52163154083346885123146186215231260274
96Week551431540833573394032540835893130162
CASTING412532540834085121157175222268
Study44163254083335695136170
Data.460932540834680103138153
Dostupné478532540834686115139179220260297
na:51053254083387286
https://medically.roche.com/global/en/medical‑material.6327f9d01652-4bcc‑b945-9dbefad807dd.qr.html?cid=slprxx2210nexxectrims2022.521432540833861871281571711992212803163583743940335408332678510213614817321324828832634037541447650454256060164367969672475879982788792496798410181054107110961158119312171253127612941329134613611399143614711506152715661608164639403454083357111014817321425829633235440043948051754458462867271373677481885889993697610201037108111071121116511911255127413051339135814021450148215011545157116091647394035540833470103136176213246280316350375398415474502538573607644658
30.39403653085367490
Weinstock405036540835792109148176200238273304
Z,437436540833852
Morrow444636540835594117140179232
S,469736540833347
Conway476436540834078118170204236
D,502036540834658
et509836540833457
al.51753654083324963
Interpreting52583654083155477112135176199234258275314355
change394037540833272106147188225
on418937540833879
the429237540832262100
Symbol441637540833364126167208226
Digit466637540834664105122146
Modalities483637540835696138173190207231249286315
Test51753754083336695120
in531937540831555
people539837540833977118160178215
with39403854083506790129
relapsing40843854083215672105145173189227267
multiple436638540835796112135152191208244
sclerosis46253854083265975111133171199215242
using48823854083376480119158
the50563854083216096
reliable5167385408321557288121161178213
change539638540833169102141181217
methodology.394039540835794117157197238277295334375409420
Mult437839540835390107129
Scler.45223954083316278109131143
2022;28(7):1101-1111.468139540833470104140154190225246282303316347376409442462495524553582593
PŘEDNÁŠKY4426266013350101144197253303348397445
4426413012382
Význam584639601335093132182227301
studie901639601333569118167191236
PEARL1152639601335091142191232
pro1399639601334981128
klinickou154263960133467194144168202248294343
praxi1900639601334981127170194
–21096399013155
MUDr.21796399013166114162188204
Jolana239863990131307191129172211
Marková,26246399013166104130169208245284303
FEAN2942639901313875123172
4426543012382
Medication5846526013370115164188222269302326372422
overuse1021652601334889133165215250295
headache1332652601335095141189235269320365
a17126526013346
role1774652601333279104149
anti-CGRP1938652601334796129153181224273324372
–23256529013155
MUDr.23956529013166114162188204
Petra2614652901314482109136175
Migaľová2804652901316685128166186227263302
4426673012382
Lékové584665601334287132177219263
interakce862665601332575108153184230275308353
migréna1231665601337598147179225274320
a15666656013347
RS1628665601335295
–17386656013355
update1808665601335099147193226271
–20936659013155
PharmDr.2163665901314487125151219267293309
Josef2488665901312970101140164
Suchopár2668665901313981113157198241280306
4426803012382
Výhody584678601335093143189238281
exibility880678601335499142166215239263286320364
podání1259678601335096145191240264
fremanezumabu1539678601333163109183229279324361410484530579628
u21826786013350
našich2247678601335196131154189239
pacientů2502678601334995129153199248282330
–28476789013155
MUDr.5846919013166114162188204
Monika8036919013166107151170207247
Záhumenská1065691901313979122164231270313344381421
ODBORNÝ38866101013353107159212263320365
GARANT42686101013352103154206262304
MUDr.38866233013166114162188204
Jolana410562330131307191129172211
Marková,43316233013166104130169208245284303
FEAN4649623301313875123172
Neurologická3886636301315190132158200220261304323355393432
klinika,433363630131396078122141178218237
Fakultní4585636301313873111154174201244263
Thomayerova4863636301313983124191230265303329371407446
nemocnice3886649301314583150191224268287319357
v42586493013138
Praze4311649301314470109143181
PARTNER3407971012153114172228299353411
POČET4357280019689201295375459
KREDITŮ4357440019693184267376418500606
2109971630541246
Registrace16267268018485162248285346399450525592667
ZDARMA16267452018687191285372499598
TERMÍN25907286019684165256388430538
prosinec25907514014568107171217244309369423
202230387514014562121178238
až25907658014558109
listopad2724765801452955101141205272330397
202331467658014562121178238
dostupný25907844014568133179219284351417470
na30857844014567124
online.solen.cz25907984014969139172205275338369422491524587658689743801
On-line3404691050329253166578589911361348
kurz176746910503230466625817
pro266346910503244403636
praktické3405091050324440361584210001118129615261732
neurology21515091050324045269184910821197143016671883
Trendy34056280390177280446632819986
v138856280390171
léčbě16205628039091256397587753
migrény24345628039027036054366783310181179
35056400901484677
202243005105075434467510011329
ONLINE28543480227131262328430486617721
KURZ104543480227116245360472